Erratum for

• Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer.

  Akechi T, Kubota Y, Ohtake Y, Setou N, Fujimori M, Takeuchi E, Kurata A, Okamura M, Hasuo H, Sakamoto R, Miyamoto S, Asai M, Shinozaki K, Onishi H, Shinomiya T, Okuyama T, Sakaguchi Y, Matsuoka H. Akechi T, et al. Jpn J Clin Oncol. 2022 May 31;52(6):650-653. doi: 10.1093/jjco/hyac025. Jpn J Clin Oncol. 2022. PMID: 35253040 Free PMC article.
• Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial).

  Naka G, Yokoyama T, Usui K, Ishida H, Kishi K, Uemura K, Ohashi Y, Kunitoh H. Naka G, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):791-794. doi: 10.1093/jjco/hyac032. Jpn J Clin Oncol. 2022. PMID: 35323965 Free PMC article.
• High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma.

  Niu Y, Wang W, Jiang X, Huang Y, Yan S, Jiang Y. Niu Y, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):759-765. doi: 10.1093/jjco/hyac040. Jpn J Clin Oncol. 2022. PMID: 35348687
• Atherosclerotic cardiovascular events associated with immune checkpoint inhibitors in cancer patients.

  Tajiri K, Sekine I. Tajiri K, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):659-664. doi: 10.1093/jjco/hyac041. Jpn J Clin Oncol. 2022. PMID: 35348725
• Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.

  Ishihara H, Nemoto Y, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Hashimoto Y, Takagi T, Ishida H, Kondo T, Tanabe K. Ishihara H, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):785-790. doi: 10.1093/jjco/hyac044. Jpn J Clin Oncol. 2022. PMID: 35373823
• Human papillomavirus-related oropharyngeal carcinoma.

  Saito Y, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Yokota T, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R. Saito Y, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):700-706. doi: 10.1093/jjco/hyac049. Jpn J Clin Oncol. 2022. PMID: 35383359 Review.
• Renal transplants with perinephric myxoid pseudotumor of fat mimicking malignancy.

  Pham M, Janiszewski RA, Stanton ML, Nguyen BD. Pham M, et al. Jpn J Clin Oncol. 2022 May 31;52(6):654-655. doi: 10.1093/jjco/hyac038. Jpn J Clin Oncol. 2022. PMID: 35383369 No abstract available.
• Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.

  Tran CT, Nguyen MV, Tran MT, Tuong TT, Tran QH, Le LC, Pham HT, Bui NC, Vu HH, Nguyen TT, Ta PQ, Ha HT, Trinh DT, Bui HT, Trinh DQ, Van Nguyen K, Le SH, Van Vu K, Van Tran T, Tran HT, Shrubsole MJ, Ye F, Cai Q, Zheng W, Boffetta P, Shu XO, Luu HN. Tran CT, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):707-715. doi: 10.1093/jjco/hyac043. Jpn J Clin Oncol. 2022. PMID: 35383373 Free PMC article.
• Role of resection for extrahepatopulmonary metastases of colon cancer.

  Mishina T, Uehara K, Ogura A, Murata Y, Aiba T, Mizuno T, Yokoyama Y, Ebata T. Mishina T, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):735-741. doi: 10.1093/jjco/hyac045. Jpn J Clin Oncol. 2022. PMID: 35393617
• Palliative radiotherapy for multiple liver metastases: a retrospective analysis of 73 cases.

  Ito K, Ogoshi Y, Shimizuguchi T. Ito K, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):779-784. doi: 10.1093/jjco/hyac050. Jpn J Clin Oncol. 2022. PMID: 35396600
• Overview of clinical management for older patients with renal cell carcinoma.

  Numakura K, Nakai Y, Kojima T, Osawa T, Narita S, Nakayama M, Kitamura H, Nishiyama H, Shinohara N. Numakura K, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):665-681. doi: 10.1093/jjco/hyac047. Jpn J Clin Oncol. 2022. PMID: 35397166 Review.
• Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors.

  Komoto I, Kokudo N, Aoki T, Morizane C, Ito T, Hashimoto T, Kimura W, Inoue N, Hasegawa K, Kondo S, Ueno H, Igarashi H, Oono T, Makuuchi M, Takamoto T, Hirai I, Takeshita A, Imamura M. Komoto I, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):716-724. doi: 10.1093/jjco/hyac048. Jpn J Clin Oncol. 2022. PMID: 35411926 Free PMC article. Clinical Trial.
• Identification of epigenetic genes for predicting prognosis and immunotherapy response of ovarian cancer.

  Shen W, Jiang W, Ye S, Sun M, Yang H, Shan B. Shen W, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):742-751. doi: 10.1093/jjco/hyac051. Jpn J Clin Oncol. 2022. PMID: 35435215
• Management of elderly patients with malignant lymphoma.

  Miyazaki K. Miyazaki K. Jpn J Clin Oncol. 2022 Jul 8;52(7):690-699. doi: 10.1093/jjco/hyac056. Jpn J Clin Oncol. 2022. PMID: 35435235
• Classification based on skeletal muscle mass and the severity of lung emphysema impacts on clinical outcomes after anatomical resection for lung cancer.

  Tsubokawa N, Mimura T, Tadokoro K, Yamashita Y. Tsubokawa N, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):917-924. doi: 10.1093/jjco/hyac057. Jpn J Clin Oncol. 2022. PMID: 35438159
• Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study.

  Tsuruta T, Todo Y, Yamada R, Kuwahara K, Kurosu H, Minowa K, Minoura Y, Minobe S, Suzuki H, Kato H. Tsuruta T, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):752-758. doi: 10.1093/jjco/hyac058. Jpn J Clin Oncol. 2022. PMID: 35438162
• The impact of death rattle on bereaved families: not the sound itself, but the resonance with their feelings.

  Yamaguchi T, Mori M, Maeda I, Matsunuma R, Tanaka-Yagi Y, Nishi T, Kizawa Y, Tsuneto S, Shima Y, Masukawa K, Miyashita M. Yamaguchi T, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):774-778. doi: 10.1093/jjco/hyac055. Jpn J Clin Oncol. 2022. PMID: 35446952
• Current status of endoscopic detection, characterization and staging of superficial esophageal squamous cell carcinoma.

  Ishihara R, Muto M. Ishihara R, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):799-805. doi: 10.1093/jjco/hyac064. Jpn J Clin Oncol. 2022. PMID: 35452124 Review.
• Current trend of radiotherapy for glioblastoma in the elderly: a survey study by the brain tumor Committee of the Korean Radiation Oncology Group (KROG 21-05).

  Wee CW, In Yoon H, Lee SW, Lim DH. Wee CW, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):843-849. doi: 10.1093/jjco/hyac060. Jpn J Clin Oncol. 2022. PMID: 35453150
• External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study.

  Utsumi T, Suzuki H, Ishikawa H, Hiroshima Y, Wakatsuki M, Harada M, Ichikawa T, Akakura K, Tsuji H. Utsumi T, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):950-953. doi: 10.1093/jjco/hyac066. Jpn J Clin Oncol. 2022. PMID: 35462397
• Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.

  Matsushita Y, Kawakami A, Sato R, Watanabe K, Watanabe H, Tamura K, Motoyama D, Ito T, Sugiyama T, Otsuka A, Miyake H. Matsushita Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):944-949. doi: 10.1093/jjco/hyac068. Jpn J Clin Oncol. 2022. PMID: 35462401
• Management of breast cancer in older patients.

  Sawaki M, Shimomura A, Shien T, Iwata H. Sawaki M, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):682-689. doi: 10.1093/jjco/hyac054. Jpn J Clin Oncol. 2022. PMID: 35462408 Clinical Trial.
• Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy.

  Ito K, Nakajima Y, Ogawa H, Taguchi K, Sugita S. Ito K, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):911-916. doi: 10.1093/jjco/hyac070. Jpn J Clin Oncol. 2022. PMID: 35462409
• Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial.

  Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito A, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Murakami N, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):859-868. doi: 10.1093/jjco/hyac072. Jpn J Clin Oncol. 2022. PMID: 35470390 Clinical Trial.
• Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.

  Moriwaki T, Nishina T, Sakai Y, Yamamoto Y, Shimada M, Ishida H, Amagai K, Sato M, Endo S, Negoro Y, Kuramochi H, Denda T, Hatachi Y, Ikezawa K, Nakajima G, Bando Y, Tsuji A, Yamamoto Y, Morimoto M, Kobayashi K, Hyodo I. Moriwaki T, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):725-734. doi: 10.1093/jjco/hyac073. Jpn J Clin Oncol. 2022. PMID: 35470391 Clinical Trial.
• Tumor mutational burden measurement using comprehensive genomic profiling assay.

  Kage H, Kohsaka S, Tatsuno K, Ueno T, Ikegami M, Zokumasu K, Shinozaki-Ushiku A, Nagai S, Aburatani H, Mano H, Oda K. Kage H, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):925-929. doi: 10.1093/jjco/hyac063. Jpn J Clin Oncol. 2022. PMID: 35482395
• Effect of adjuvant chemotherapy on periosteal osteosarcoma: a systematic review.

  Tsukamoto S, Righi A, Kido A, Honoki K, Tanaka Y, Fujii H, Mavrogenis AF, Tanaka Y, Errani C. Tsukamoto S, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):896-904. doi: 10.1093/jjco/hyac059. Jpn J Clin Oncol. 2022. PMID: 35485208
• Management of elderly patients with esophageal squamous cell cancer.

  Hamamoto Y, Murakami K, Kato K, Kitagawa Y. Hamamoto Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):816-824. doi: 10.1093/jjco/hyac067. Jpn J Clin Oncol. 2022. PMID: 35511482 Free PMC article. Review.
• Current trends in chemotherapy for advanced ovarian cancer.

  Takahashi N, Takekuma M. Takahashi N, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):806-815. doi: 10.1093/jjco/hyac065. Jpn J Clin Oncol. 2022. PMID: 35521913 Review.
• Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer.

  Wada Y, Okano K, Sato K, Sugimoto M, Shimomura A, Nagao M, Matsukawa H, Ando Y, Suto H, Oshima M, Kondo A, Asano E, Kishino T, Kumamoto K, Kobara H, Kamada H, Masaki T, Soga T, Suzuki Y. Wada Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):887-895. doi: 10.1093/jjco/hyac074. Jpn J Clin Oncol. 2022. PMID: 35523689
• Interim results from a postmarketing surveillance study of patients with FLT3-mutated relapsed/refractory AML treated with the FLT3 inhibitor gilteritinib in Japan.

  Sugamori H, Lee T, Mitomi T, Yamagishi C. Sugamori H, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):766-773. doi: 10.1093/jjco/hyac069. Jpn J Clin Oncol. 2022. PMID: 35523692 Free PMC article.
• International variations in neuroblastoma incidence in children and adolescents.

  Okawa S, Saika K. Okawa S, et al. Jpn J Clin Oncol. 2022 May 31;52(6):656-658. doi: 10.1093/jjco/hyac079. Jpn J Clin Oncol. 2022. PMID: 35551398 No abstract available.
• Optimal managements of elderly patients with glioblastoma.

  Arakawa Y, Mineharu Y, Uto M, Mizowaki T. Arakawa Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):833-842. doi: 10.1093/jjco/hyac075. Jpn J Clin Oncol. 2022. PMID: 35552425 Free PMC article. Review.
• Correction to: Current trend of radiotherapy for glioblastoma in the elderly: a survey study by the brain tumor Committee of the Korean Radiation Oncology Group (KROG 21-05).

  Wee CW, In Yoon H, Lee SW, Lim DH. Wee CW, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):798. doi: 10.1093/jjco/hyac088. Jpn J Clin Oncol. 2022. PMID: 35575259 No abstract available.
• A pilot study examining the efficacy of hochuekkito for improving quality of life in patients with myeloproliferative neoplasms.

  Edahiro Y, Koike M, Nojiri S, Harada Y, Gotoh A, Fujibayashi K, Nishizaki Y, Yanagisawa N, Takaku T, Nitta H, Tsukune Y, Misawa K, Kobayashi H, Komatsu N. Edahiro Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):880-886. doi: 10.1093/jjco/hyac076. Jpn J Clin Oncol. 2022. PMID: 35575284 Clinical Trial.
• Identification of distinct genomic features reveals frequent somatic AHNAK and PTEN mutations predominantly in primary malignant melanoma presenting in the ureter.

  Huang Y, Wei L, Huang Y, Wen S, Liu T, Duan X, Wang Y, Zhang H, Fan B, Hu B. Huang Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):930-943. doi: 10.1093/jjco/hyac061. Jpn J Clin Oncol. 2022. PMID: 35578896 Review.
• Current practice of pharmacological treatment for hyperactive delirium in terminally ill cancer patients: results of a nationwide survey of Japanese palliative care physicians and liaison psychiatrists.

  Matsuda Y, Morita T, Oya K, Tagami K, Naito AS, Kashiwagi H, Otani H. Matsuda Y, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):905-910. doi: 10.1093/jjco/hyac081. Jpn J Clin Oncol. 2022. PMID: 35595535
• Current treatment status of older patients with gynecological cancers.

  Yunokawa M, Onda T, Ishikawa M, Yaegashi N, Kanao H. Yunokawa M, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):825-832. doi: 10.1093/jjco/hyac082. Jpn J Clin Oncol. 2022. PMID: 35640242 Review.
• A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial.

  Ohue M, Iwasa S, Mizusawa J, Kanemitsu Y, Shiozawa M, Nishizawa Y, Ueno H, Katsumata K, Yasui M, Tsukamoto S, Katayama H, Fukuda H, Shimada Y. Ohue M, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):850-858. doi: 10.1093/jjco/hyac080. Jpn J Clin Oncol. 2022. PMID: 35640246 Free PMC article. Clinical Trial.
• Development and validation of a nomogram for prognosis of sinonasal adenocarcinoma (a nomogram for sinonasal adenocarcinoma).

  Huang H, Chen K, Deng L, Chen Y, Zhao D, Lin W. Huang H, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):869-879. doi: 10.1093/jjco/hyac083. Jpn J Clin Oncol. 2022. PMID: 35642571 Clinical Trial.
• International variations in renal tumours incidence in children and adolescents.

  Charvat H, Nakata K. Charvat H, et al. Jpn J Clin Oncol. 2022 Jul 8;52(7):795-797. doi: 10.1093/jjco/hyac104. Jpn J Clin Oncol. 2022. PMID: 35714352 No abstract available.
• Correction to: The characteristics of missed pharyngeal and laryngeal cancers at gastrointestinal endoscopy.

  [No authors listed] [No authors listed] Jpn J Clin Oncol. 2022 Aug 5;52(8):957. doi: 10.1093/jjco/hyac117. Jpn J Clin Oncol. 2022. PMID: 35815436 No abstract available.
• International variations in hepatic tumours incidence in children and adolescents.

  Saika K, Gatellier L. Saika K, et al. Jpn J Clin Oncol. 2022 Aug 5;52(8):954-956. doi: 10.1093/jjco/hyac115. Jpn J Clin Oncol. 2022. PMID: 35862986 No abstract available.